Device Satisfaction

Documentation: GMSS, IDSS

Glucose Monitoring System Satisfaction Survey (GMSS)

The GMSS is a 15-item self-report scale, with separate versions for subjects with type 1 diabetes (T1D) and type 2 diabetes (T2D). The T1D version includes 4 subscales, which capture the following key dimensions: openness, emotional burden, behavioral burden and trust. The T2D version also includes 4 subscales: openness, emotional burden, behavioral burden and worthwhileness.

First published in 2015, it is already been selected as an important outcome measures in upcoming studies.

This copyrighted scale is available free of charge to non-profit institutions for use in clinical care and research.

However, payment of a per use licensing fee is required for all for-profit companies and other for-profit institutions. To find out more about licensing procedures and fees in regards to for-profit organizations, please contact us at info@behavioraldiabetes.org.

We have many translations available for download. It has come to our attention that several of the translated versions have changed the order and some content of the scale items. This may make the order and content of the subscales unreliable. We caution anyone who is using translated versions and who wishes to make use of the subscales to make certain that the order and content of the items match the original English version

The key GMSS publication is:

Title: Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life

Date: 2015

Authors: Polonsky WH, Fisher L, Hessler D, Edelman SV.

Insulin Delivery Satisfaction Survey (IDSS)

The IDSS is a self-report scale with two versions, a 14-item version for subjects with type 1 diabetes (T1D) and a 12-item version for subjects with type 2 diabetes (T2D). The T1D version includes 3 subscales, which capture the following key dimensions: effectiveness, burdensomeness and inconvenience. The T2D version also includes 3 subscales: difficulty, usefulness and freeing.

First published in 2015, it is already been selected as an important outcome measures in upcoming studies.

This copyrighted scale is available free of charge to non-profit institutions for use in clinical care and research.

At this time, the two IDSS versions are only available in English and Turkish.

The key IDSS publication is:

Title: Development of a new measure for assessing insulin delivery device satisfaction in patients with type 1 and type 2 diabetes.

Date:2015

Authors: Polonsky WH, Fisher L, Hessler D, Edelman SV.

JOIN US FOR A LOCAL EVENT

Monthly Events

August 14 - 16. Taking Control of Your Diabetes (TCOYD) will be hosting the in-person ONE event, an amazing weekend experience here in San Diego for more than 500 people with type 1 diabetes and their loved ones. Dr. Polonsky is honored to be one of the presenters, and we will hope to see many of you there. There are still a few spaces left, so if you’d like to know more, please visit

August 29: Time for another T1D meet-up! GrownupT1Ds, a wonderful nonprofit that organizes fun social events for adults with type 1 diabetes here in southern California and now spreading to other cities across the United States. The next local one will be at Forest Lanes (yes, it’s a Bowling Meetup!), 22771 Centre Dr, Lake Forest (CA), starting at 3:00 pm. And you can find out about other upcoming GrownupT1Ds events around the country (Philadelphia, New York City, Raleigh and more) at grownupt1ds.org

September 9: BDI hosts the San Diego-wide, monthly case consultation meeting (for mental health professionals working in the field of diabetes). Contact us at info@behavioraldiabetes.org if you are in the greater San Diego area and would like further information about this program.

On October 24, BDI will host a live, one-day, CME workshop: Engaging the Disengaged: Innovative Strategies for Promoting Behavior Change in Diabetes. Run by Dr. Polonsky (BDI President) and Dr. Guzman (BDI Clinic Director), Participants will deepen their skills in recognizing and addressing common barriers to effective self-care and cardiometabolic medication initiation and maintenance, while fostering respectful, stigma-free clinical encounters.